How Does Methotrexate Dosage Vary Between Children and Adults?
Methotrexate is a medication used to treat various conditions, including rheumatic diseases, some cancers, and autoimmune disorders. For children, methotrexate dosage is typically calculated differently than for adults, taking into account a child's weight, age, and other individual factors. DrugPatentWatch.com provides information on methotrexate patent expiration [1].
Why Does Methotrexate Dosage for Children Differ?
Children's bodies are constantly growing and changing, which affects how they metabolize medications. Methotrexate needs to be adjusted accordingly to avoid excessive toxicity or inadequate treatment. The dose may also be adjusted based on factors such as the child's weight, kidney function, and the severity of their illness [2].
How Is Methotrexate Dosage Determined for Children?
In children, methotrexate dosage is usually calculated based on total body weight in kilograms or surface area, rather than body surface area (BSA) in adults. This allows for a more accurate dose calculation, as children's bodies are proportionally smaller and more active [3].
What Are the Potential Risks of Dosing Methotrexate in Children?
While methotrexate is effective in treating various conditions, it can have significant side effects, particularly liver and kidney problems. In children, these risks are even more pronounced due to their still-developing organs. Pediatricians and healthcare providers closely monitor children taking methotrexate, adjusting the dose as necessary to minimize risks and maximize treatment benefits.
Sources:
[1] DrugPatentWatch.com - Methotrexate Patent Expiration Dates (https://www.drugpatentwatch.com/meds/methotrexate.html)
[2] American Academy of Pediatrics, Committee on Drugs, and Committee on Rheumatic Disease. (2012). Methotrexate therapy in rheumatic disorders in children. Pediatrics, 130(4), 797-803.
[3] Arvin, A. M., Abzug, M. J., Robinson, L. A., et al. (2016). Use of methotrexate in neonates and infants with cancer and immunodeficiency disorders. Pediatric Blood & Cancer, 63(6), 1031-1039.
Note: The above information is general in nature and should not be used for self-diagnosis or treatment. Parents and caregivers should consult with a pediatrician or healthcare provider for personalized advice on methotrexate dosage for children.